New safety study links sedative use to increased stroke risk. A large UK study involving more than 165,000 people with dementia has found that the drug risperidone increases the risk of stroke in all ...

Two new groundbreaking drugs could slow the memory impairment, thinking skills and overall brain decline — and both are ...

A breakthrough new Alzheimer’s disease treatment is stopping neurodegeneration in its tracks, even before symptoms appear.

New research suggests Alzheimer’s may start far earlier than previously thought, driven by a hidden toxic protein in the brain. Scientists found that an experimental drug, NU-9, blocks this early ...

Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company focused on developing innovative treatments for Alzheimer's disease, Parkinson's ...

Although he struggles with his memory, Roy Mitchell knows he is glad to be among the first patients in the world to try a new medicine for Alzheimer's disease. The first four people have been enrolled ...

Data included more than a million participants to find that Alzheimer's risk was up to 76% lower in these cases.

Jason Mast is a general assignment reporter at STAT focused on the science behind new medicines and the systems and people that decide whether that science ever reaches patients. You can reach Jason ...

Patients with Alzheimer's who took a GLP-1 drug improved their memory scores and lost less of their brains.

Prescriptions for the nerve-pain drug have doubled in 15 years as doctors moved away from opioids and benzodiazepines.• ...